Michael Friedlander Selected Research

Michael Friedlander Research Topics

Disease

85	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 04/2003
64	Neoplasms (Cancer) 04/2024 - 04/2005
25	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2005
19	Carcinoma (Carcinomatosis) 05/2023 - 05/2004
18	Fatigue 02/2024 - 10/2006
11	Disease Progression 01/2023 - 05/2014
10	Peripheral Nervous System Diseases (PNS Diseases) 04/2024 - 01/2015
9	Ovarian Epithelial Carcinoma 06/2023 - 03/2009
8	Anemia 06/2023 - 05/2010
8	Nausea 06/2023 - 07/2010
8	Neutropenia 01/2022 - 10/2014
4	Ascites 02/2024 - 10/2018
4	Endometrial Neoplasms (Endometrial Cancer) 12/2022 - 01/2019
4	Thrombocytopenia (Thrombopenia) 10/2021 - 10/2014
4	Vomiting 10/2021 - 04/2012
3	Fallopian Tube Neoplasms 01/2021 - 12/2018
2	Hypersensitivity (Allergy) 04/2024 - 04/2003
2	Obesity 04/2024 - 01/2022
2	Chronic Disease (Chronic Diseases) 02/2024 - 05/2010
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2022 - 09/2011
2	Asthenia 10/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2006
2	Clear Cell Adenocarcinoma 01/2020 - 04/2011
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 12/2009
2	Hypertension (High Blood Pressure) 03/2016 - 10/2014
2	Residual Neoplasm 02/2015 - 03/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2015 - 04/2003
2	Mood Disorders (Mood Disorder) 01/2011 - 10/2006
2	Colorectal Neoplasms (Colorectal Cancer) 07/2007 - 07/2006
1	Hypesthesia (Numbness) 04/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2023
1	Turcot syndrome 12/2022
1	Hyperplasia 01/2022

Drug/Important Bio-Agent (IBA)

52	PlatinumIBA 02/2024 - 04/2003
31	olaparibIBA 02/2024 - 07/2010
27	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2023 - 07/2010
22	Paclitaxel (Taxol)FDA LinkGeneric 04/2024 - 03/2009
20	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 04/2003
11	veliparibIBA 01/2024 - 02/2017
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2011
9	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2023 - 09/2011
5	Immune Checkpoint InhibitorsIBA 12/2022 - 04/2018
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 07/2006
5	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 03/2009
5	Hormones (Hormone)IBA 01/2021 - 04/2005
4	thiaclopridIBA 12/2023 - 09/2011
4	Poly Adenosine Diphosphate RiboseIBA 01/2023 - 09/2011
4	paragonIBA 10/2021 - 01/2019
4	Capsules (Microcapsules)IBA 10/2021 - 02/2016
4	TabletsIBA 01/2021 - 01/2017
4	Anastrozole (Arimidex)FDA LinkGeneric 09/2019 - 11/2014
3	AntigensIBA 01/2023 - 09/2011
3	durvalumabIBA 12/2022 - 01/2020
3	Estrogen ReceptorsIBA 09/2019 - 04/2005
3	Estrogens (Estrogen)FDA Link 09/2019 - 04/2017
3	Aromatase InhibitorsIBA 01/2019 - 10/2008
3	pazopanib FDA Link 03/2016 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2011
3	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 04/2003
2	Bevacizumab (Avastin)FDA Link 02/2024 - 05/2014
2	human ERBB2 proteinIBA 01/2024 - 01/2021
2	rucaparibIBA 06/2023 - 01/2017
2	CreatinineIBA 01/2023 - 10/2011
2	B7-H1 AntigenIBA 12/2022 - 01/2020
2	ChromatinIBA 12/2022 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 09/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 02/2019
2	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019 - 04/2012
2	Adenosine Diphosphate (ADP)IBA 12/2019 - 04/2012
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2018 - 12/2009
2	Tamoxifen FDA LinkGeneric 01/2017 - 11/2014
2	Gemcitabine FDA Link 01/2015 - 03/2009
2	Angiogenesis InhibitorsIBA 04/2011 - 10/2010
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 12/2004
1	LipidsIBA 04/2024
1	Triglycerides (Triacylglycerol)IBA 04/2024
1	Cell-Free Nucleic AcidsIBA 02/2024
1	ErbB Receptors (EGF Receptor)IBA 02/2024
1	niraparibIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	CBLC137IBA 12/2022
1	AlpelisibIBA 10/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022

Therapy/Procedure

71	Drug Therapy (Chemotherapy) 04/2024 - 04/2003
59	Therapeutics 02/2024 - 10/2006
5	Adjuvant Chemotherapy 02/2024 - 11/2006
5	Aftercare (After-Treatment) 01/2022 - 08/2007
4	Radiotherapy 02/2024 - 04/2003
3	Mastectomy (Mammectomy) 01/2022 - 07/2012
3	Cytoreduction Surgical Procedures 01/2015 - 10/2010
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 05/2015
2	Neoadjuvant Therapy 08/2016 - 02/2015
2	Hysterectomy 02/2015 - 11/2013
2	Salpingo-oophorectomy 07/2012 - 04/2004
1	Retreatment 04/2024
1	Drug Tapering 04/2024
1	Subcutaneous Mastectomy 01/2022